Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY

Sotera Health Sees IBD RS Rating Rise To 72

On Thursday, Sotera Health received a positive adjustment to its Relative Strength (RS) Rating, from 62 to 72.

This unique rating tracks technical performance by showing how a stock's price action over the last 52 weeks measures up against that of the other stocks in our database.

Decades of market research reveals that the top-performing stocks tend to have an RS Rating of at least 80 as they begin their biggest price moves. See if Sotera Health can continue to rebound and hit that benchmark.

How To Invest In Stocks In Both Bull And Bear Markets

Sotera Health is trying to complete a cup with handle with a 17.08 entry. See if the stock can break out in heavy trading.

Sotera Health reported 6% earnings growth last quarter, while sales growth came in at 8%.

The company holds the No. 5 rank among its peers in the Medical-Services industry group. Hims & Hers Health is the No. 1-ranked stock within the group.

RELATED:

Stocks With Rising Relative Strength Ratings

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Ready To Grow Your Investing Skills? Join An IBD Meetup Group!

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.